Press Releases
Filters
April 1, 2024
Viatris Announces the Launch of RYZUMVl™ (Phentolamine Ophthalmic Solution) 0.75% in the United States
March 27, 2024
Viatris Hosts R&D Event Focusing on its Collaboration with Idorsia, Phase 3 Assets Selatogrel and Cenerimod and Key Elements of its Pipeline
March 18, 2024
Viatris Statement Regarding the Closing of Global Research and Development Collaboration with Idorsia
March 11, 2024
Viatris and Mapi Pharma Statement Regarding New Drug Application for GA Depot
February 28, 2024
Viatris Reports Fourth-Quarter and Full-Year 2023 Financial Results and Provides 2024 Financial Guidance
February 28, 2024
Viatris and Idorsia Enter Into Significant Global Research and Development Collaboration
Displaying 31 - 40 of 137